Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising Acrinova in its rights issue
Mandate

Vinge is advising Acrinova in its rights issue

May 07, 2021 Capital Markets and Public M&A

Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK 130 million.

Acrinova is an entrepreneurial-run real estate company operating in southern Sweden with a focus on the Öresund region. Acrinova’s property portfolio is developed through acquisitions, project development and refinement.

Acrinova is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Linnéa Sellström, Julia Hirschberg and Lorin Arabi.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025